Pulmonary arterial hypertension trials in Sweden

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  Where

  Linkoping, Umea

  Age

  18 years to 75 years

  People

  344 worldwide

  Run by

  Insmed Incorporated

  See details and how to joinNCT07481981 · EU 2026-525265-48-00
• Phase 3Enrolling by invitation
  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Where

  Gothenburg, Linköping, Umeå

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT03683186 · EU 2023-509305-68-00